CLZ-1001

N/A

Report date: 2023/08/04 13:44:09

Base Information

Drug NameCLZ-1001
Drug Alias NameEmbryonic stem cell-derived MusculoSkeletal Stem Cell Therapy (Cellatoz Therapeutics)ES-MSSC (Cellatoz Therapeutics)CLZ-1001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsPeriodontal DiseasesCartilage DiseasesOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellatoz Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellatoz Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPeriodontal DiseasesCartilage DiseasesOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A